TN2010000602A1 - Pyrimidine derivatives as kinase inhibitors - Google Patents
Pyrimidine derivatives as kinase inhibitorsInfo
- Publication number
- TN2010000602A1 TN2010000602A1 TNP2010000602A TN2010000602A TN2010000602A1 TN 2010000602 A1 TN2010000602 A1 TN 2010000602A1 TN P2010000602 A TNP2010000602 A TN P2010000602A TN 2010000602 A TN2010000602 A TN 2010000602A TN 2010000602 A1 TN2010000602 A1 TN 2010000602A1
- Authority
- TN
- Tunisia
- Prior art keywords
- pyrimidine derivatives
- kinase inhibitors
- analplastic
- igf
- alk
- Prior art date
Links
- 229940083082 pyrimidine derivative acting on arteriolar smooth muscle Drugs 0.000 title abstract 3
- 150000003230 pyrimidines Chemical class 0.000 title abstract 3
- 229940043355 kinase inhibitor Drugs 0.000 title 1
- 239000003757 phosphotransferase inhibitor Substances 0.000 title 1
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 abstract 1
- 206010025323 Lymphomas Diseases 0.000 abstract 1
- 108091000080 Phosphotransferase Proteins 0.000 abstract 1
- 102000013275 Somatomedins Human genes 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000005764 inhibitory process Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 102000020233 phosphotransferase Human genes 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention provides novel pyrimidine derivatives of formula I and pharmaceutical compositions thereof, and methods for using such compounds. For example, the pyrimidine derivatives of the invention may be used to treat, ameliorate or prevent a condition which responds to inhibition of insulin- like growth factor (IGF-IR) or analplastic lymphoma kinase (ALK).
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US2009/048428 WO2010002655A2 (en) | 2008-06-25 | 2009-06-24 | Compounds and compositions as kinase inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TN2010000602A1 true TN2010000602A1 (en) | 2012-05-24 |
Family
ID=55024677
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TNP2010000602A TN2010000602A1 (en) | 2009-06-24 | 2010-12-24 | Pyrimidine derivatives as kinase inhibitors |
Country Status (1)
| Country | Link |
|---|---|
| TN (1) | TN2010000602A1 (en) |
-
2010
- 2010-12-24 TN TNP2010000602A patent/TN2010000602A1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2010002655A3 (en) | Pyrimidine derivatives as kinase inhibitors | |
| UA101057C2 (en) | Pyrimidine derivatives as kinase inhibitors | |
| MX2010002336A (en) | Compounds and compositions as kinase inhibitors. | |
| UA100846C2 (en) | Compounds and compositions as protein kinase inhibitors | |
| MX2010010968A (en) | Compounds and compositions as protein kinase inhibitors. | |
| MX2012000711A (en) | Pyrrolopyrazine inhibitors of kinases. | |
| MX2009006081A (en) | Compounds and compositions as protein kinase inhibitors. | |
| WO2009126514A8 (en) | Compounds and compositions as kinase inhibitors | |
| MX2012013197A (en) | Indazole inhibitors of kinase. | |
| MX2012000709A (en) | Pyrrolopyridine inhibitors of kinases. | |
| MX2011013325A (en) | 2- ( lh-pyrazol-4 -ylamino ) -pyrimidine as kinase inhibitors. | |
| MX2009000884A (en) | Pyridizinone derivatives. | |
| MX336726B (en) | Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors. | |
| GEP20135964B (en) | Inhibitors of beta-secretase | |
| MX2013001361A (en) | 4-(1h-indol-3-yl) -pyrimidines as alk inhibitors. | |
| AU2011276193A8 (en) | Bipyridyl derivatives useful for the treatment of kinase - induced diseases | |
| IN2012DN01641A (en) | ||
| MY149512A (en) | Pyrazolylaminopyridine derivatives useful as kinase inhibitors | |
| MX2012004780A (en) | Akt inhibitors. | |
| MX2011012631A (en) | Pyrimidine inhibitors of kinase activity. | |
| MX2011012629A (en) | Pyrimidine inhibitors of kinase activity. | |
| MX2011012632A (en) | Pyrimidine inhibitors of kinase activity. | |
| WO2009094560A3 (en) | Thienopyranones as kinase inhibitors | |
| WO2010039668A3 (en) | Inhibitors of cyclin kinase inhibitor p21 | |
| MX2010004604A (en) | Pyrazole derivatives as 5-lo inhibitors. |